These tandem duplications were characterised into two different rearrangement signatures [87]: one enriched in areas that disrupted tumour suppressor genes such as PTEN and RB1, and the other enriched in oncogenes, including MYC, and in putative regulatory elements of genes such as ESR1, with direct effects on transcription [87]. The gene discussed is PTEN; the disease is neoplasm.